{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:05:07Z","timestamp":1778717107029,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91556","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T22:25:09Z","timestamp":1756938309000},"source":"Crossref","is-referenced-by-count":1,"title":["Residual Eosinophilic Inflammation of Sinonasal Mucosa Under the Maintenance Phase of Eosinophilic Granulomatosis With Polyangiitis"],"prefix":"10.7759","author":[{"given":"Masaaki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Nishisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuko","family":"Ainai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goichi","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens WJ","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al.. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020, 58:1-464. 10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.07.002","article-title":"Eosinophilic chronic rhinosinusitis","volume":"68","author":"Fujieda S","year":"2019","unstructured":"Fujieda S, Imoto Y, Kato Y, et al.. Eosinophilic chronic rhinosinusitis. Allergol Int. 2019, 68:403-12. 10.1016\/j.alit.2019.07.002","journal-title":"Allergol Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato A","year":"2022","unstructured":"Kato A, Schleimer RP, Bleier BS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. 2022, 149:1491-503. 10.1016\/j.jaci.2022.02.016","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga T","year":"2015","unstructured":"Tokunaga T, Sakashita M, Haruna T, et al.. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study. Allergy. 2015, 70:995-1003. 10.1111\/all.12644","journal-title":"Allergy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2024.11.010","article-title":"Biologics treatment for eosinophilic chronic rhinosinusitis complicated by bronchial asthma: narrative review","volume":"63","author":"Nagano T","year":"2025","unstructured":"Nagano T. Biologics treatment for eosinophilic chronic rhinosinusitis complicated by bronchial asthma: narrative review. Respir Investig. 2025, 63:35-9. 10.1016\/j.resinv.2024.11.010","journal-title":"Respir Investig"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23234","article-title":"Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy","volume":"14","author":"Papacharalampous GX","year":"2024","unstructured":"Papacharalampous GX, Constantinidis J, Fotiadis G, et al.. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. Int Forum Allergy Rhinol. 2024, 14:96-109. 10.1002\/alr.23234","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato A","year":"2022","unstructured":"Kato A, Peters AT, Stevens WW, et al.. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022, 77:812-26. 10.1111\/all.15074","journal-title":"Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: a review","volume":"22","author":"White J","year":"2023","unstructured":"White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: a review. Autoimmun Rev. 2023, 22:103219. 10.1016\/j.autrev.2022.103219","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi G","year":"2023","unstructured":"Emmi G, Bettiol A, Gelain E, et al.. Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023, 19:378-93. 10.1038\/s41584-023-00958-w","journal-title":"Nat Rev Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler ME","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D, et al.. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017, 376:1921-32. 10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07133-w","article-title":"Three cases of relapsed eosinophilic sinusitis without eosinophilia during mepolizumab maintenance therapy for eosinophilic granulomatosis with polyangiitis","volume":"43","author":"Nishisaka K","year":"2024","unstructured":"Nishisaka K, Ueda Y, Inoue M, et al.. Three cases of relapsed eosinophilic sinusitis without eosinophilia during mepolizumab maintenance therapy for eosinophilic granulomatosis with polyangiitis. Clin Rheumatol. 2024, 43:3577-80. 10.1007\/s10067-024-07133-w","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham JG","year":"1984","unstructured":"Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984, 63:65-81. 10.1097\/00005792-198403000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi AT","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT, et al.. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990, 33:1094-100. 10.1002\/art.1780330806","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2007.02.004","article-title":"The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?","volume":"137","author":"Hopkins C","year":"2007","unstructured":"Hopkins C, Browne JP, Slack R, et al.. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?. Otolaryngol Head Neck Surg. 2007, 137:555-61. 10.1016\/j.otohns.2007.02.004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal outcome test","volume":"34","author":"Hopkins C","year":"2009","unstructured":"Hopkins C, Gillett S, Slack R, et al.. Psychometric validity of the 22-item Sinonasal outcome test. Clin Otolaryngol. 2009, 34:447-54. 10.1111\/j.1749-4486.2009.01995.x","journal-title":"Clin Otolaryngol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4193\/Rhino15.072","article-title":"Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments","volume":"54","author":"Toma S","year":"2016","unstructured":"Toma S, Hopkins C. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016, 54:129-33. 10.4193\/Rhino15.072","journal-title":"Rhinology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.1095","article-title":"Mepolizumab reduces inflammatory eosinophils in nasal polyp tissue and restores histological alterations","author":"Matucci A","year":"2025","unstructured":"Matucci A, Accinno M, Maggiore G, et al.. Mepolizumab reduces inflammatory eosinophils in nasal polyp tissue and restores histological alterations. J Investig Allergol Clin Immunol. 2025, 10.18176\/jiaci.1095","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14152","article-title":"Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis","volume":"52","author":"Walter S","year":"2022","unstructured":"Walter S, Ho J, Alvarado R, et al.. Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis. Clin Exp Allergy. 2022, 52:1403-13. 10.1111\/cea.14152","journal-title":"Clin Exp Allergy"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.05.009","article-title":"Comparison of clinical characteristics of the nasal manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) and eosinophilic chronic rhinosinusitis (ECRS)","volume":"70","author":"Suzuki M","year":"2021","unstructured":"Suzuki M, Nakazono A, Morita S, et al.. Comparison of clinical characteristics of the nasal manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) and eosinophilic chronic rhinosinusitis (ECRS). Allergol Int. 2021, 70:143-4. 10.1016\/j.alit.2020.05.009","journal-title":"Allergol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/403544-residual-eosinophilic-inflammation-of-sinonasal-mucosa-under-the-maintenance-phase-of-eosinophilic-granulomatosis-with-polyangiitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T22:25:09Z","timestamp":1756938309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/403544-residual-eosinophilic-inflammation-of-sinonasal-mucosa-under-the-maintenance-phase-of-eosinophilic-granulomatosis-with-polyangiitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.91556","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}